These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9873502)

  • 21. Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.
    Ono K; Yoshida A; Saito N; Fujishima T; Honzawa S; Suhara Y; Kishimoto S; Sugiura T; Waku K; Takayama H; Kittaka A
    J Org Chem; 2003 Sep; 68(19):7407-15. PubMed ID: 12968893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators.
    Fujishima T; Kittaka A; Yamaoka K; Takeyama K; Kato S; Takayama H
    Org Biomol Chem; 2003 Jun; 1(11):1863-9. PubMed ID: 12945766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Removal of the 26-methyl group from 19-nor-1α,25-dihydroxyvitamin D₃ markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription.
    Grzywacz P; Chiellini G; Plum LA; Clagett-Dame M; DeLuca HF
    J Med Chem; 2010 Dec; 53(24):8642-9. PubMed ID: 21105677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluations of A-ring isomers of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
    Ikeda M; Takahashi K; Dan A; Koyama K; Kubota K; Tanaka T; Hayashi M
    Bioorg Med Chem; 2000 Aug; 8(8):2157-66. PubMed ID: 11003160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological properties of seco-d-ring modified 1α,25-dihydroxyvitamin D
    Szybinski M; Sektas K; Sicinski RR; Plum LA; Frelek J; DeLuca HF
    J Steroid Biochem Mol Biol; 2017 Jul; 171():144-154. PubMed ID: 28285018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Biological Activity of 2-Methylene Analogues of Calcitriol and Related Compounds.
    Sibilska IK; Szybinski M; Sicinski RR; Plum LA; DeLuca HF
    J Med Chem; 2015 Dec; 58(24):9653-62. PubMed ID: 26574921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arocalciferols: synthesis and biological evaluation of aromatic side-chain analogues of 1 alpha,25-dihydroxyvitamin D3(1a).
    Figadère B; Norman AW; Henry HL; Koeffler HP; Zhou JY; Okamura WH
    J Med Chem; 1991 Aug; 34(8):2452-63. PubMed ID: 1652020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain.
    Sicinski RR; Rotkiewicz P; Kolinski A; Sicinska W; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 2002 Aug; 45(16):3366-80. PubMed ID: 12139448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New 1 alpha,25-dihydroxy vitamin D3 analogues with side chains attached to C-18: synthesis and biological activity.
    Grue-Sørensen G; Hansen CM
    Bioorg Med Chem; 1998 Nov; 6(11):2029-39. PubMed ID: 9881094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient synthesis and biological evaluation of all A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 and its 20-epimer.
    Fujishima T; Konno K; Nakagawa K; Kurobe M; Okano T; Takayama H
    Bioorg Med Chem; 2000 Jan; 8(1):123-34. PubMed ID: 10968271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs.
    Chen YJ; Gao LJ; Murad I; Verstuyf A; Verlinden L; Verboven C; Bouillon R; Viterbo D; Milanesio M; Van Haver D; Vandewalle M; De Clercq PJ
    Org Biomol Chem; 2003 Jan; 1(2):257-67. PubMed ID: 12929421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A concise and efficient route to 2alpha-(omega-hydroxyalkoxy)-1alpha,25-dihydroxyvi tam in D3: remarkably high affinity to vitamin D receptor.
    Kittaka A; Suhara Y; Takayanagi H; Fujishima T; Kurihara M; Takayama H
    Org Lett; 2000 Aug; 2(17):2619-22. PubMed ID: 10990411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues.
    Schepens W; Van Haver DV; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3889-92. PubMed ID: 15225691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation.
    Fujishima T; Kittaka A; Kurihara M; Saito N; Honzawa S; Kishimoto S; Sugiura T; Waku K; Takayama H
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):89-92. PubMed ID: 15225752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New 1alpha,25-dihydroxy-19-norvitamin D(3) compounds constrained in a single A-ring conformation: synthesis of the analogues by ring-closing metathesis route and their biological evaluation.
    Glebocka A; Sokolowska K; Sicinski RR; Plum LA; Deluca HF
    J Med Chem; 2009 Jun; 52(11):3496-504. PubMed ID: 19402630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of new aromatic (C17-C20)-locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D(3)).
    Fernández-Gacio A; Vitale C; Mouriño A
    J Org Chem; 2000 Oct; 65(21):6978-83. PubMed ID: 11031019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation.
    Sicinski RR; Glebocka A; Plum LA; DeLuca HF
    J Med Chem; 2007 Nov; 50(24):6154-64. PubMed ID: 17960924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 13,13-Dimethyl-des-C,D analogues of (20S)-1α,25-dihydroxy-2-methylene-19-norvitamin D₃ (2MD): total synthesis, docking to the VDR, and biological evaluation.
    Plonska-Ocypa K; Sibilska I; Sicinski RR; Sicinska W; Plum LA; DeLuca HF
    Bioorg Med Chem; 2011 Dec; 19(23):7205-20. PubMed ID: 22018918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.